Modeling the disruption of respiratory disease clinical trials by non-pharmaceutical COVID-19 interventions

Respiratory disease trials are profoundly affected by non-pharmaceutical interventions (NPIs) against COVID-19 because they perturb existing regular patterns of all seasonal viral epidemics. To address trial design with such uncertainty, we developed an epidemiological model of respiratory tract inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Arsène, Simon, Couty, Claire, Faddeenkov, Igor, Go, Natacha, Granjeon-Noriot, Solène, Šmít, Daniel, Kahoul, Riad, Illigens, Ben, Boissel, Jean-Pierre, Chevalier, Aude, Lehr, Lorenz, Pasquali, Christian, Kulesza, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008035/
https://www.ncbi.nlm.nih.gov/pubmed/35418135
http://dx.doi.org/10.1038/s41467-022-29534-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008035/
https://www.ncbi.nlm.nih.gov/pubmed/35418135
http://dx.doi.org/10.1038/s41467-022-29534-8

Ejemplares similares